Ildong Esomeprazole Magnesium Trihydrate 20 mg
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.
MFDS item code 202003750 · Approved 2020.05.22
This product's status changed to Approval withdrawn on 2024.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and gastrointestinal symptoms), and Zollinger-Ellison syndrome
This medication is used for long-term maintenance therapy to treat gastroesophageal reflux disease (GERD) and erosive reflux esophagitis, and to prevent recurrence. It is also utilized in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection. Additionally, it provides short-term relief from upper gastrointestinal symptoms such as pain, discomfort, and burning sensations associated with NSAID use. It also aids in the treatment of gastric ulcers and the prevention of gastric and duodenal ulcers related to ongoing NSAID therapy. It is used to treat Zollinger-Ellison syndrome and to prevent rebleeding of gastric or duodenal ulcers, thereby stabilizing the patient's condition. Overall, it improves gastrointestinal health and is effective in treating various gastrointestinal diseases.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and administered twice daily. 6) Maintenance therapy after intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Older adults No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years of age There is no experience with administration of this drug to children under 12 years of age.
This medication should not be administered to certain patients. It must not be taken by those with hypersensitivity to this drug or its components, or to benzimidazole derivatives. Patients allergic to certain antibiotics such as amoxicillin or clarithromycin during Helicobacter pylori eradication therapy should also refrain from using this drug. It is advisable for individuals with a history of myocardial infarction or those who are breastfeeding to avoid this medication. This drug contains the dye Yellow No. 5; therefore, those with allergies or hypersensitivity to this component should use it cautiously. While taking this medication, there may be various adverse reactions. Blood-related issues such as leukopenia or thrombocytopenia may occur rarely, and severe allergic reactions may also happen infrequently. Electrolyte disturbances like hypomagnesemia have been reported rarely, and this may accompany calcium or potassium deficiencies. Mental symptoms such as insomnia, anxiety, depression, and hallucinations may occur, and headaches or dizziness may frequently be experienced. Gastrointestinal issues including abdominal pain, constipation, diarrhea, nausea, and vomiting can occur commonly, although severe problems such as pancreatitis or gastric mucosal inflammation may rarely arise. Severe skin reactions such as rashes, itching, hair loss, and in severe cases, Stevens-Johnson syndrome have also been reported. Muscle pain or joint pain may occur, and renal issues such as nephritis can very rarely be encountered. This medication may mask symptoms of malignant tumors when used over a long duration, so if there are symptoms like weight loss, recurrent vomiting, blood vomiting, or black stools, consulting a doctor is essential. Regular examinations are necessary for prolonged use over one year, and immediate medical attention should be sought if there are changes in symptoms. This drug can lower gastric acidity, increasing the risk of bacterial infections; therefore, if diarrhea persists for a long time, the healthcare provider should be informed. There may be an increased risk of fractures with prolonged high-dose use, so periodic monitoring is required for those at risk of osteoporosis. Additionally, prolonged use beyond three months may lead to hypomagnesemia, necessitating regular checks of magnesium levels. This drug has numerous interactions with other medications, so caution is required, especially when used with anticoagulants, antibiotics, antiviral drugs, and anticonvulsants. Patients should always inform their doctor or pharmacist about any currently taken medications, as interactions with other drugs can cause adverse effects. Data on the safety of this medication during pregnancy are limited, so pregnant women should take it cautiously under a doctor’s guidance, and it is preferable to avoid it during breastfeeding. There is no specific antidote for overdose, so appropriate management should be provided based on symptoms, and this drug binds strongly to proteins in the blood, making it unrecoverable through dialysis. Lastly, this drug should be kept out of the reach of children, and transferring it to another container can lead to quality degradation or accidents, so caution is advised.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, hepatic failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, coughing, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular urticaria, otitis media, altered sense of smell, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, micturition frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric hyperplastic polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it should be kept at a temperature between 1 and 30 degrees Celsius (room temperature). Therefore, always make sure to close the lid well when storing the medication and avoid extremely hot or cold places.
Pale pink oblong film-coated tablets
28 tablets/box [14 tablets/Alu-Alu*2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.